Human Immunodeficiency Virus Type I Enhancer Binding Protein 2 (HIVEP2) (C-Term) Peptid
HIVEP2
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle HIVEP2 Produkte
- HIVEP2 (Human Immunodeficiency Virus Type I Enhancer Binding Protein 2 (HIVEP2))
- Protein-Typ
- Synthetic
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- HIVEP2 peptide is a synthetic peptide cooresponding to 13 amino acids from the C-Terminus of HIVEP2.
-
-
- Applikationshinweise
- HIVEP2 Peptide is used for blocking the activity of HIVEP2 antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- HIVEP2 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 ?L water, the concentration will be 0.5 mg/mL.
- Handhabung
- When reconstituted minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C.
-
- Target
- HIVEP2 (Human Immunodeficiency Virus Type I Enhancer Binding Protein 2 (HIVEP2))
- Synonyme
- HIVEP2 Peptide, si:ch211-157m21.1 Peptide, MIBP1 Peptide, Schnurri-2 Peptide, Shn-2 Peptide, HIV-EP2 Peptide, MBP-2 Peptide, SHN2 Peptide, ZAS2 Peptide, ZNF40B Peptide, human immunodeficiency virus type I enhancer binding protein 2 Peptide, human immunodeficiency virus type I enhancer binding protein 2 L homeolog Peptide, human immunodeficiency virus type I enhancer binding protein 2a Peptide, HIVEP2 Peptide, hivep2.L Peptide, hivep2a Peptide, hivep2 Peptide, Hivep2 Peptide
- Gen-ID
- 3097
- NCBI Accession
- NP_005682, NP_064693
- UniProt
- P31629
-
Sie sind hier:
